G Pharma Spaces Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 11 Year, 10 Months
- Last Filing with ROC 31 Mar 2020
About G Pharma Spaces
G Pharma Spaces Private Limited (GPSPL) is a Private Limited Indian Non-Government Company incorporated in India on 28 March 2013 and has a history of 11 years and ten months. Its registered office is in Raigarh, Maharashtra, India.
The Company is engaged in the Construction Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rekha Sharma and Upendra Sharma serve as directors at the Company.
Company Details
- Location
Raigarh, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U36931MH2013PTC241418
- Company No.
241418
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Mar 2013
- Date of AGM
31 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
What products or services does G Pharma Spaces Private Limited offer?
G Pharma Spaces Private Limited offers a wide range of products and services, including Stained, Etched & Laminated Glass, Sheet Glass, Window Glass, Window, Glass Windows, Doors and Windows, Bathroom Door, Glass Doors, Toughened Glass, Roofing and False ceiling.
Who are the key members and board of directors at G Pharma Spaces?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rekha Sharma  | Director | 28-Mar-2013 | Current |
| Upendra Sharma | Director | 28-Mar-2013 | Current |
Financial Performance of G Pharma Spaces.
G Pharma Spaces Private Limited, for the financial year ended 2016, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of G Pharma Spaces?
In 2016, G Pharma Spaces had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at G Pharma Spaces?
G Pharma Spaces has a workforce of 6 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of G Pharma Spaces, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped G Pharma Spaces's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
